Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by iamjunobazon Jul 03, 2020 12:48pm
239 Views
Post# 31221091

RE:RE:RE:RE:RE:RE: LXG final redesigned instrument

RE:RE:RE:RE:RE:RE: LXG final redesigned instrumentAbout 12 months ago they set about redesigning the machine for commercialisation. The original design means it would have cost 100k and would have been bulky 

With the expertise they employed the machine has shrunk into a much smaller package with much higher accuracy and will be sold at a price that is very competitive at a good margin

The reason for the FDA timeline is they have only recently finished the final design and tested it in DHMC. Now they are happy with everything and know it works as expected in the commercial packaging they can apply for FDA

I believe pre  FDA submissions are ongoing,through July and August they will continue to test and submit data to further their FDA application which should result in approval in September or slightly sooner

Launch to the World of the final machine design should be around the 14TH of July 


<< Previous
Bullboard Posts
Next >>